Tag: Type 1 Diabetes
Portal Diabetes achieves Breakthrough designation from FDA for implantable insulin pump
February 17, 2026HME News Staff
WESTFIELD, Ind. – Portal Diabetes has received Breakthrough Device Designation by the Food and Drug Administration (FDA) for its implantable insulin pump system called Portal Pump, and the start of a Phase 1 study on its proprietary temperature-stable insulin, Portal Insulin. The company aims to deliver a functional cure to type 1 diabetes – an implantable insulin pump leveraging the physiologic delivery of insulin to the abdomen, modern continuous glucose monitoring...
Pump up the superpower: Insulet, Marvel launch comic hero with Type 1 diabetes
September 12, 2025Tracy Orzel
ACTON, Mass. – Strapping on an insulin pump may not always feel heroic, but Insulet and Marvel are changing that narrative with a new comic that puts a character with Type 1 diabetes at the center of the story.
“At Insulet, we know representation matters and it has a direct impact on how kids and teens embrace diabetes technology,” said Lucas Escobar, the company’s director of U.S. consumer marketing. “That belief drove us to collaborate with Marvel, one of...
Barbie gets a CGM, but will Medicare beneficiaries keep theirs?
August 11, 2025Theresa Flaherty, Managing Editor
I’m out of shape. That is, I was feeling out of shape, and out of my element, when, ahead of the July 4th holiday, I found myself trying to report and write an initial follow-up story to CMS’s proposed plans for the next round of competitive bidding.
Bid ceilings? Remote Item Delivery? Wake me up when it’s over.
But I’m here today to talk specifically about the proposal to include continuous glucose monitors (CGMs) in the program. Providers are, once...
In brief: CQRC’s bid concerns, NCPA’s latest PBM push, AAH's new leaders
July 11, 2025HME News Staff
WASHINGTON – The Council for Quality Respiratory Care (CQRC) is concerned that Medicare’s proposed competitive bidding program could have substantial negative consequences on patient access and quality of care. The council says it's time to pass reform that permanently removes the supplemental oxygen benefit from the program.
“While we continue to review the proposed rule to understand its full impact and scope, the CQRC is deeply concerned the methodology proposed...
Mattel launches Barbie with Type 1 diabetes, CGM
July 9, 2025HME News Staff
EL SEGUNDO, Calif. – Mattel is debuting the first Barbie doll with Type 1 diabetes (T1D). This addition enables more children to see themselves reflected in Barbie and encourages doll play that extends beyond a child’s own lived experience, thereby fostering a greater sense of inclusion and empathy – all pillars of the Barbie brand’s mission, the company says. “Introducing a Barbie doll with Type 1 diabetes marks an important step in our commitment to inclusivity and...
Edgepark adds new automated insulin delivery device to portfolio
February 14, 2024HME News Staff
TWINSBURG, Ohio – Edgepark is now offering the newly launched Beta Bionics iLet Bionic Pancreas fully automated insulin delivery (AID) system as part of its comprehensive diabetes management solution portfolio. The iLet does not require carbohydrate counting for carb-aware users and fully automates 100% of insulin doses. Designed for anyone 6 years of age and older living with Type 1 diabetes, it eliminates the traditional manual work previously involved with using an insulin pump. “It’s...
When it comes to technology, sometimes the journey is the point
December 15, 2022Theresa Flaherty, Managing Editor
I’m on information overload this week and it’s only Wednesday. And it’s technology information that I’m being inundated with. It’s exhausting.
Take work. We are switching to new laptops. This is a good thing. But in the lead up to the big switch, I had to start backing up my files differently (In the air! Somewhere!). Now, I’m not a Luddite, by any means, but some concepts are a tad bit harder for me to wrap my mind around. I have a perfectly serviceable...
MiniMed analysis shows high rates of time in range
June 3, 2021HME News Staff
DUBLIN, Ireland – Diabetes patients using Medtronics’ MiniMed 780G system saw an average overall time in range of 76.2% and an overnight time in range of 83%, according to an analysis of 4,120 individuals with Type 1 diabetes. "It is extremely encouraging to see Medtronic advancing both clinical outcomes, as well as the user experience through their latest MiniMed 780G system,” said Prof. Chantal Mathieu, endocrinologist at University Hospitals Leuven-KULeuven, Belgium. “It...
Dispatches from the dining room: Flattening the (blood sugar) curve
April 20, 2020Theresa Flaherty, Managing Editor
Appropriate to my current WFH status, I also had my first ever telehealth appointment last week, with Sarah the CDE. It was simply a three-month check-in to see how I was doing with diabetes management, including what patterns have been cropping up in my blood sugar numbers, and where I could make changes to fine-tune things.
On the plus side, I've been getting in more exercise because I force myself out for walks whenever the weather is agreeable (so, about half as often as I—or Sarah—would...
Ascensia participates in fundraiser
February 14, 2020HME News Staff
BASEL, Switzerland - Ascensia Diabetes Care is supporting the 2020 Spare a Rose Campaign, a fundraiser to provide insulin, testing supplies and education for children with Type 1 diabetes in countries with limited access. The Spare a Rose campaign, created by Life for a Child, encourages people to buy at least one less rose for their loved ones on Valentine's day and instead donate $5 to Life for a Child. Ascensia will match employee donations up to $8,500, representing one rose per employee. Over...